Melanotan-II

Skin Pigmentation

Sexual Health

What is Melanotan-II? Benefits, Research & Legality (2025 Guide)

Melanotan-II is a synthetic peptide designed to mimic the effects of α-MSH, a naturally occurring hormone that influences skin pigmentation, appetite, and sexual behavior. Its unique ability to stimulate melanogenesis and enhance skin pigmentation without UV exposure has made it popular for cosmetic and research purposes. Additionally, its effects on appetite suppression and sexual function have broadened its potential therapeutic applications.

Melanotan-II

Overview

Melanotan-II (MT-II) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH), primarily recognized for its ability to promote skin pigmentation and tanning by stimulating melanin production. Developed initially as a potential photoprotective agent to reduce UV-induced skin damage, MT-II activates melanocortin receptors, particularly MC1R in melanocytes, enhancing melanin synthesis and resulting in a natural-looking tan without significant sun exposure. Beyond its tanning capabilities, MT-II has demonstrated notable effects in appetite suppression, making it a candidate for obesity and weight management treatments by influencing caloric intake and energy balance. Additionally, Melanotan-II exhibits aphrodisiac properties, significantly impacting sexual desire and improving sexual function in both men and women by acting on central melanocortin pathways. Despite its promising benefits, MT-II is not yet FDA-approved and remains under extensive clinical investigation to better understand its full therapeutic potential, safety, optimal usage, and potential side effects. Ongoing research continues to explore its broad applications, including in dermatology, metabolic medicine, sexual health, and potentially in protective treatments against sun-induced skin conditions, highlighting its diverse and intriguing therapeutic possibilities.

What is

Melanotan-II

?

Melanotan-II (MT-II) is a synthetic peptide analog of the naturally occurring hormone α-melanocyte-stimulating hormone (α-MSH), primarily recognized for its ability to stimulate melanogenesis—the process of pigmentation in the skin. Initially developed to promote sunless tanning, Melanotan-II has also been studied for its potential in appetite suppression, sexual dysfunction, and weight management. Although not FDA-approved for general use, ongoing research supports its multifaceted therapeutic potential.

How it Might Work

Enhanced Skin Pigmentation

Melanotan-II works by activating melanocortin receptors, particularly MC1R in melanocytes, stimulating melanin production in the skin. Increased melanin enhances skin pigmentation, providing a tanned appearance and offering improved protection against UV-induced damage. This property has significant cosmetic appeal and therapeutic potential for conditions involving photosensitivity or pigmentation disorders.

Appetite Suppression and Weight Management

Melanotan-II also interacts with MC3R and MC4R melanocortin receptors, influencing appetite regulation and energy homeostasis. Its ability to suppress appetite and reduce caloric intake has been demonstrated in preclinical studies, suggesting potential for weight management and obesity treatment. This effect has increased interest in Melanotan-II as a possible therapeutic agent for controlling body weight.

Improvement in Sexual Function

Notably, Melanotan-II has demonstrated aphrodisiac effects in preclinical and clinical studies, influencing sexual desire and erectile function through its action on central melanocortin pathways. Its ability to enhance sexual behavior and treat certain forms of sexual dysfunction has expanded its potential clinical applications beyond cosmetic and weight management.

What People are Saying

Popularity in Cosmetic and Fitness Communities

Melanotan-II has gained considerable attention in cosmetic and fitness circles due to its effectiveness in promoting rapid tanning without significant sun exposure. Users frequently highlight its convenient and pronounced tanning effects, reduced appetite, and improved body composition, driving its widespread popularity despite the lack of formal FDA approval.

Cautious Interest from Medical Researchers

The medical research community acknowledges Melanotan-II’s unique potential across various applications, including weight management, sexual health, and dermatology. Researchers consistently emphasize the need for comprehensive safety evaluations, controlled clinical trials, and precise therapeutic guidelines before broader clinical adoption.

Caution from Healthcare Providers

Healthcare providers maintain a cautious stance regarding Melanotan-II, acknowledging promising preliminary findings but highlighting potential side effects and safety concerns. Medical professionals advocate for extensive clinical trials and stringent safety assessments to clarify appropriate usage, dosage, and long-term safety profiles.

What its Being Studied for

Sunless Tanning and Skin Protection

Melanotan-II is extensively studied for its ability to induce sunless tanning by stimulating melanin production. Research consistently demonstrates its effectiveness in increasing skin pigmentation, potentially reducing the risk of sun-induced skin damage and photoaging, which positions it as an appealing alternative to traditional tanning methods.

Obesity and Appetite Regulation

Due to its appetite-suppressing effects, Melanotan-II has significant potential in managing obesity and aiding weight loss. Studies suggest it effectively reduces food intake and influences body weight regulation, indicating substantial promise for obesity treatment and dietary interventions.

Sexual Dysfunction Treatment

Melanotan-II’s aphrodisiac properties have led to research exploring its potential for managing sexual dysfunction, particularly erectile dysfunction and hypoactive sexual desire disorders. Clinical findings indicate positive outcomes in enhancing sexual desire and improving erectile function, supporting further investigation into therapeutic applications.

Research Use Only

Melanotan-II is strictly intended for laboratory and clinical research:

  • Available exclusively from authorized research suppliers

  • Not FDA-approved for general therapeutic use

  • Comprehensive safety, efficacy, and dosage guidelines remain under ongoing investigation

FAQ

Is Melanotan-II legally available?

Yes, Melanotan-II is legally available for research purposes from specialized suppliers but is not approved for general therapeutic or cosmetic use.

Have human trials been conducted with Melanotan-II?

Limited human trials have provided initial positive results regarding tanning efficacy, appetite suppression, and sexual enhancement. However, extensive research is required for comprehensive clinical validation.

What are potential side effects of Melanotan-II?

Potential side effects include nausea, flushing, fatigue, and increased pigmentation of moles or freckles. Severe long-term side effects remain inadequately studied, highlighting the need for further research.

How is Melanotan-II typically administered?

Melanotan-II is typically administered through subcutaneous injections in research settings, with dosage protocols adjusted based on specific experimental objectives.

Can Melanotan-II be combined with other peptides or treatments?

While often explored in research, interactions between Melanotan-II and other peptides or treatments require careful, controlled investigation to ensure safety and efficacy.

Does Melanotan-II provide permanent tanning or weight loss?

Melanotan-II induces temporary tanning and appetite suppression effects during active administration. Sustained outcomes generally require ongoing or repeated treatments.

Dive Into the Research

Hadley, M.E., & Dorr, R.T. (2006). Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides.

Dorr, R.T., et al. (2004). Increased eumelanin expression and tanning is induced by subcutaneous administration of Melanotan II, a cyclic melanotropin analogue. Journal of Investigative Dermatology.

Wessells, H., et al. (2000). Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. International Journal of Impotence Research.

(The above references are representative and support the research context of MOTS-c. All claims are for research purposes only and do not imply approved medical use.)

Picture of Jake Reynolds

About the Author

Jake Reynolds

Jake is a wellness writer and certified health coach who got into peptides and GLPs while trying to solve his own burnout. He now shares clear, well researched resources to help others cut through the confusion and take better control of their health.

Last Updated

June 18, 2025

Exploring the future of regenerative science

Exploring the future of regenerative science

Exploring the future of regenerative science